Author | Jack Cuzick, PhD


HPV Vaccines Continue to Improve, But More Uptake Required

September 24, 2015

In this interview we discuss the latest on HPV vaccines for cancer prevention and some of the struggles countries face in achieving widespread adoption.

Duration of Aromatase Inhibitor Treatment in Breast Cancer: The Role of the ‘Carryover Effect’

December 15, 2013

The so-called “carryover” effect of tamoxifen results in the reduction in recurrence continuing well after treatment has stopped. The carryover effect is seen mostly in the first 5 years after treatment cessation, and recent evidence suggests that after that time, it is largely over.